2021 annual financial data
Keros Therapeutics 2021 Operating margin
Direct answer
Operating margin was -280.46%.
Operating income was -56,373,000 USD and net income was -58,744,000 USD.
Operating cash flow was -62,148,000 USD.
Get free Keros Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 20,100,000 USD
- Operating income
- -56,373,000 USD
- Net income
- -58,744,000 USD
- Operating cash flow
- -62,148,000 USD